Richter's Transformation clinical trials at UC Health
1 research study open to eligible people
A Study of ARQ 531 in Patients With Selected Hematologic Malignancies
open to eligible people ages 18 years and up
This is an open-label, multi-center Phase 1/2 study of ARQ 531 in patients with selected hematologic malignancies.
at UCLA
Last updated: